Back to the main directory
Press Release
- Repligen Reports Fourth Quarter and Full Year 2024 Financial Results by GlobeNewsWire
- FTI Consulting Reports Fourth Quarter and Full Year 2024 Financial Results by GlobeNewsWire
- Gold-Rich Cobalt-Copper Mineralization at CAS Property Strengthens Electra’s Idaho Exploration Strategy by GlobeNewsWire
- Hardman & Co publication on Real Estate Credit Investments (RECI) - The rise of private credit: threats and opportunities by EQS Group AG
- Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failur by Newsfile Corp.
- ParaZero Unlocks Growth Opportunities After Achieving European Regulatory Compliance for its SafeAir Systems by GlobeNewsWire
- Mainz Biomed Expands into Switzerland with labor team w by GlobeNewsWire
- XBP Europe Selected for AGIRC-ARRCO’s Digital Transformation Framework by GlobeNewsWire
- Stellantis Unveils STLA AutoDrive, Hands-Free and Eyes-Off Autonomous Technology for a New Era of Driving Comfort by GlobeNewsWire
- Pacira to Report 2024 Financial Results on Thursday February 27, 2025 by GlobeNewsWire
- Fiverr Launches a Freelancer Equity Program to Give Direct Stake in the Business by GlobeNewsWire
- Sprott Launches Active Gold & Silver Miners ETF by GlobeNewsWire
- Growth in Originations Expected Across Multiple Credit Products in 2025 by GlobeNewsWire
- Aterian Issues Letter to Shareholders by GlobeNewsWire
- Armlogi Advances Supply Chain Solutions with Roadie, a UPS Company, Expanding Last-Mile Delivery Coverage to 97% of U.S. by GlobeNewsWire
- JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis by GlobeNewsWire
- Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes by GlobeNewsWire
- Oxford Lane Capital Corp. Prices Public Offering of $165,000,000 7.95% Notes Due 2032 by GlobeNewsWire
- Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025 by GlobeNewsWire
- PDS Biotech to Participate at B. Riley Securities Precision Oncology & Radiopharma Conference 2025 by GlobeNewsWire
- El Pollo Loco Expands Popular Mango Habanero Flavor to Tostadas by GlobeNewsWire
- ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables by GlobeNewsWire
- Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress by GlobeNewsWire
- FuelCell Energy Releases 2024 Annual and Sustainability Reports by GlobeNewsWire
- TMX VettaFi acquiert les indices obligataires Credit Suisse auprès d'UBS by Newsfile Corp.